1050553

Medpace, Inc. — FEI 3009316555

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 20, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cincinnati, OH (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
745321 CFR 312.56(b)Investigator non-compliance
748221 CFR 312.50General responsibilities of sponsors